A. Arvin M.

A. Arvin M. has extensive experience in the pharmaceutical and healthcare industries, currently serving as Key Account Manager for Melinta Therapeutics since August 2018, focusing on rare infectious diseases in Washington State, Northern Idaho, and Alaska. Previous roles include Executive Cardiovascular Account Specialist at Novartis, where A. Arvin M. managed key health systems across the Pacific Northwest, and Institutional and Hospital Account Representative at Daiichi Sankyo, emphasizing cardiovascular specialty sales. Other notable positions include Territory Account Manager at Oscient Bio-Pharmaceuticals, and various management roles at Overlake Hospital and Group Health/Kaiser Permanente. A. Arvin M. holds a BA in Political Science and Government from Seattle University and a Master of Public Administration in Health Care Administration from Eastern Washington University.